Short answer
Quest Diagnostics (DGX) filed its Q2 2026 10-Q quarterly report on Jul 23, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $3.0B (up 10.2% year over year) with net income of $320M.
Q2 2026 key financials · XBRL
- Revenue
- $3.0B
- +10.2% YoY · +5.1% QoQ
- Net income
- $320M
- +13.5% YoY · +27.0% QoQ
- Operating margin
- 15.1%
- EPS (diluted)
- $2.84
- +15.0% YoY · +26.8% QoQ
Source: XBRL data from the Quest Diagnostics (DGX) Q2 2026 10-Q on SEC EDGAR. USD.
Quest Diagnostics Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $3,043M, up 10.2% YoY from $2,761M, driven by DIS revenue growth
- Operating margin 15.1% vs 15.9% YoY; net income $320M vs $282M
- Best segment DIS revenue $2,978M, up 10.3%; DS revenue $65M, up 4.3%
- Operating cash flow $597M vs $544M; capital expenditures $138M vs $108M
- $500M 5.00% senior notes issued; $500M 3.45% notes repaid at maturity
- Near-term headwinds: compensation costs, reimbursement pressures, inflation, and revenue per requisition down 2.8%
Risk Factors
- Risk factors section not provided in submitted filing text
- No new, changed, regulatory, operational, competitive, market, or financial risk disclosed in provided excerpt
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Quest Diagnostics quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.